Articles liés à Tumors of the Central Nervous System: Gliomas: Glioblastoma...
L'édition de cet ISBN n'est malheureusement plus disponible.
Afficher les exemplaires de cette édition ISBN
- ÉditeurSpringer
- Date d'édition2011
- ISBN 10 9400706170
- ISBN 13 9789400706170
- ReliureRelié
- Numéro d'édition1
- Nombre de pages458
- ÉditeurHayat M.A.
Acheter neuf
En savoir plus sur cette édition
EUR 180,07
Frais de port :
EUR 48,99
De Allemagne vers Etats-Unis
Meilleurs résultats de recherche sur AbeBooks
Image fournie par le vendeur
Tumors of the Central Nervous System, Volume 2
Edité par
Springer Netherlands
(2011)
ISBN 10 : 9400706170
ISBN 13 : 9789400706170
Neuf
Couverture rigide
Quantité disponible : > 20
Vendeur :
Evaluation vendeur
Description du livre Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. 1. Targeted therapy determined by molecular genetics is emphasized. 2.Several imaging techniques for diagnosis and treatment assessment are detailed. 3.Present and future therapeutic drugs against malignant gliomas are described. 4.The anti-tumor action of . N° de réf. du vendeur 5825375
Acheter neuf
EUR 180,07
Autre devise
Image fournie par le vendeur
Tumors of the Central Nervous System, Volume 2
Edité par
Springer Netherlands Apr 2011
(2011)
ISBN 10 : 9400706170
ISBN 13 : 9789400706170
Neuf
Couverture rigide
Quantité disponible : 2
Vendeur :
Evaluation vendeur
Description du livre Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. 480 pp. Englisch. N° de réf. du vendeur 9789400706170
Acheter neuf
EUR 213,99
Autre devise
Image fournie par le vendeur
Tumors of the Central Nervous System, Volume 2 : Gliomas: Glioblastoma (Part 2)
Edité par
Springer Netherlands
(2011)
ISBN 10 : 9400706170
ISBN 13 : 9789400706170
Neuf
Couverture rigide
Quantité disponible : 1
Vendeur :
Evaluation vendeur
Description du livre Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. N° de réf. du vendeur 9789400706170
Acheter neuf
EUR 217,79
Autre devise